This Viewpoint from the National Academy of Medicine’s 2016 Vital Directions initiative proposes improvements to the design of health benefits in the United States to enable more effective, efficient, and affordable care for patients.
This Viewpoint addresses the benefits and challenges of adopting indication-specific pricing for cancer drugs.
This retrospective study reports that more competition among US physicians is related to lower prices paid by private preferred provider organizations for office visits.
This analysis of claims data from employer-insured patients found that those who accessed a pricing platform to check the cost of clinician visits, laboratory testing services, or imaging studies had lower total claims payments than those who did not check prices.
Robinson and Miller determine whether total expenditures per patient were higher in medical groups owned by local hospitals or multihospital systems compared with groups owned by participating physicians in California between 2009 and 2012.
This population epidemiology study uses administrative data to compare differences in spending, utilization, and patient experiences associated with an accountable care organization vs traditional fee for service among Medicare beneficiaries.